Tag: VP

Generative AI is advancing rapidly, but so are creative ways people find to use it maliciously. Many governments are trying to speed up their regulating plans to mitigate the risk of AI misuse. Meanwhile, some generative AI developers are looking into how they could help secure their models and services….

•  LIBRA trial designed to support registration of TP-03 in China•  Topline results expected in the fourth quarter of 2023 SHANGHAI, China and PRINCETON, N.J., June 08, 2023 (GLOBE NEWSWIRE) — LianBio (Nasdaq: LIAN), a biotechnology company dedicated to bringing innovative medicines to patients in China and other major Asian…

NEW YORK – In releasing a major update to its strategic roadmap last month, the Global Alliance for Genomics and Health (GA4GH) is, among other goals, looking to become more relevant in clinical genomics. “We … are really concerned about making sure our standards are used in the real world,…

(Source: Weights & Biases) Weights & Biases unveiled two new products at its inaugural in-person conference in San Francisco. The company is known for its AI and machine learning development tools, and it previously released a new suite of LLMOps (large language model operations) tools in April to support the…

•  LIBRA trial designed to support registration of TP-03 in China•  Topline results expected in the fourth quarter of 2023 SHANGHAI, China and PRINCETON, N.J., June 08, 2023 (GLOBE NEWSWIRE) — LianBio (Nasdaq: LIAN), a biotechnology company dedicated to bringing innovative medicines to patients in China and other major Asian…

Intelligent Contact Center Momentum Sets the Stage for Joint Generative AI Innovation SAN FRANCISCO & SUNNYVALE, Calif.–(BUSINESS WIRE)– Twilio Inc. (NYSE: TWLO), the customer engagement platform that drives real-time, personalized experiences for today’s leading brands, and Google Cloud today announced an expansion of their long-standing partnership to bring Google Cloud…

WHO. World malaria report 2021. Geneva: World Health Organization; 2021. Google Scholar  CDC, Global. COVID-19: centres for disease control and prevention; 2021. www.cdc.gov/coronavirus/2019-ncov/global-covid-19/index.html. Accessed 14 Dec 2021. Sidhu ABS, Valderramos SG, Fidock DA. Pfmdr1 mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum. Mol Microbiol. 2005;57:913–26. Article …

Twilio unveils CustomerAI ahead of SIGNAL, its upcoming user and developer conference, and simultaneously expands on its long-standing partnership with Google Cloud. Debuting in a new video, Twilio’s CustomerAI couples the power of large language models (LLMs) with the rich customer data that flows through Twilio’s Customer Engagement Platform to…

Integration with Google Cloud and Joint Go to Market Will Extend Typeface’s Highly Customized Generative AI to Businesses and Workspace Users SAN FRANCISCO , June 7, 2023 /PRNewswire/ — Typeface, the generative AI platform for enterprise content creation, today announced a major partnership and deep technology integration with Google Cloud…

LianBio SHANGHAI, China and PRINCETON, N.J., June 06, 2023 (GLOBE NEWSWIRE) — LianBio (Nasdaq: LIAN), a biotechnology company dedicated to bringing innovative medicines to patients in China and other major Asian markets, today announced positive topline results from a Phase 2a proof of concept trial evaluating infigratinib in Chinese patients…

About Jason Restivo has over fifteen years of experience in the entertainment and advertising industries. Jason is currently the Head of Storytelling at RStudio, a position they have held since January of 2022. Prior to their current role, Jason served as the Managing Director of Brand & Advertising at Charles…

Key Takeaways: Grid Dynamics will partner with Google to implement Google Cloud LLMs and Vertex AI solutions. The expanded Grid Dynamics relationship with Google Cloud reflects the company’s position as an industry leader in AI and enables the company to accelerate the development of innovative, industry-specific AI solutions for global…

June 6, 2023 – 4:05 pm Key Takeaways: Grid Dynamics will partner with Google to implement Google Cloud LLMs and Vertex AI solutions. The expanded Grid Dynamics relationship with Google Cloud reflects the company’s position as an industry leader in AI and enables the company to accelerate the development of…

Key Takeaways: Grid Dynamics will partner with Google to implement Google Cloud LLMs and Vertex AI solutions. The expanded Grid Dynamics relationship with Google Cloud reflects the company’s position as an industry leader in AI and enables the company to accelerate the development of innovative, industry-specific AI solutions for global…

Key Takeaways: Grid Dynamics will partner with Google to implement Google Cloud LLMs and Vertex AI solutions. The expanded Grid Dynamics relationship with Google Cloud reflects the company’s position as an industry leader in AI and enables the company to accelerate the development of innovative, industry-specific AI solutions for global…

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here. TransCode Therapeutics, Inc. (NASDAQ: RNAZ) today announced acceptance for publication by Frontiers in Molecular Biosciences of a preclinical study using TransCode’s lead therapeutic candidate, TTX-MC138, in glioblastoma multiforme (GBM). The findings of…

Stayntouch, a global leader in cloud hotel property management systems (PMS) and guest-centric technology, today announced a partnership with Waikiki Malia, a popular hotel offering a contemporary retreat in the heart of Waikiki, Hawaii. Waikiki Malia chose Stayntouch to deliver its intuitive cloud PMS to empower staff, streamline operations, and…

Results from two promising trials in the fight against head and neck cancer have been presented at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago. Transgene, a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, and NEC Corporation, a provider of IT,…

Adjusting a mass spectrometer for protein sequencing The REpAb® technology is well-positioned to fit into any therapeutic antibody discovery pipeline. KITCHENER, Ontario (PRWEB) June 05, 2023 Rapid Novor Inc., the world’s leader in mass spectrometry (MS)-based antibody protein sequencing, announced today that its REpAb® antibody discovery platform was used…

Jerome Pesenti is the former VP of AI at Meta, a tech conglomerate that includes Facebook, WhatsApp, and Instagram, and one of the most exciting places where AI research is happening today. Jerome shares his thoughts on Transformers-based large language models, and why he’s excited by the progress but skeptical…

NEW YORK – Roche subsidiary Foundation Medicine and German pharmaceutical company Merck KGaA announced on Monday that they have entered a strategic collaboration to develop companion diagnostics for the US market.  The companies will develop the FoundationOne CDx and FoundationOne Liquid CDx tests as companion diagnostics for selected marketed and…

Wipro‘s avalanche of top-tier losses persists, with two senior vice presidents being the most recent to leave the business. The most recent being the heads of Wipro’s healthcare and manufacturing departments. Mohd Haque, the senior vice president and the head of Wipro’s Healthcare & Medical Devices group, will leave the…

Illumina: Stephen MacMillan, Scott Ullem Illumina has added Hologic CEO Stephen MacMillan and Scott Ullem, CFO of Edwards Lifesciences, to its board of directors, effective immediately. MacMillan will also serve as non-executive chair of the board. The moves come just a week after shareholders voted to replace previous chair John…

A group of international researchers has shed further light on genetic variants responsible for human diseases by analysing primate DNA data with a novel AI algorithm. Initially, the scientists sequenced over 800 individual samples from 233 species of non-human primates representing all 16 families, from lemurs to gorillas. To interpret…

Can-Fite to Participate in Out-licensing and Distribution Partnering Meetings at Bio International Convention in Boston Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncology, inflammatory and liver diseases, today announced its VP of Business Development, Dr. Sari…

The need for a more complete understanding of primate genetic diversity is urgent, especially given the threats posed by factors such as climate change, habitat loss, and illegal trading and hunting. Characterizing primate variation not only allows us to better understand and conserve these species in the wild, but it…

Dave Morgenstern, PhD DELFI Diagnostics, a pioneering developer of a new class of high-performance, accessible liquid biopsy tests for early cancer detection and monitoring, has hired Dave Morgenstern, PhD, as Vice President of Clinical Development. Dave joins DELFI from Roche Diagnostics, where he spent more than a decade in clinical development…

Correa P, Houghton J. Carcinogenesis of Helicobacter pylori. Gastroenterology. 2007;133(2):659–72. Article  CAS  PubMed  Google Scholar  Dube C, Tanih N, Ndip R. Helicobacter pylori in water sources: a global environmental health concern. Rev Environ Health. 2009;24(1):1–14. Article  CAS  Google Scholar  Stark RM, Gerwig GJ, Pitman RS, Potts LF, Williams NA, Greenman…

VGXI has long been recognized for its exceptional quality in DNA products and services, and under Mr. Whitmore’s leadership, the company aims to fuel rapid growth, consolidate its global brand positioning, and expand its client base. CONROE, Texas (PRWEB) May 31, 2023 VGXI Inc., a distinguished Texas-based Contract Development…

Credit: koto_feja/Getty Images Cell and gene therapy have surprisingly long histories. Cell therapy has existed in the form of bone marrow transplant, used to treat cancers and other conditions, since the late 1950’s, although it only came to prominence with the approval of the first chimeric antigen receptor (CAR) T-cell…

Introduction Mycobacterium tuberculosis (MTB) infection in humans leading to tuberculosis (TB), which is an ancient infectious disease that threatens public health.1 TB can be categorized as extrapulmonary TB (EPTB) or pulmonary TB according to the status of MTB infection in the lungs.2 Notably, EPTB is the collective term for all…

WHO. Guidelines for malaria. WHO/UCN/GMP/2022.01 Rev. 2. Geneva. World Health Organization; 2022. Nzoumbou-Boko R, Panté-Wockama CBG, Ngoagoni C, Petiot N, Legrand E, Vickos U, et al. Molecular assessment of kelch13 non-synonymous mutations in Plasmodium falciparum isolates from central African Republic (2017–2019). Malar J. 2020;19:191. Article  CAS  PubMed  PubMed Central  Google…

NVIDIA Corp. (NASDAQ:NVDA) Q1 2024 Earnings Conference Call May 24, 2023 5:00 PM ET Company Participants Simona Jankowski – VP, IR Colette Kress – EVP & CFO Jensen Huang – Co-Founder, CEO & President Conference Call Participants Toshiya Hari – Goldman Sachs C.J. Muse – Evercore ISI Vivek Arya –…

24K-Production Shares of small molecule developer Fulcrum Therapeutics (NASDAQ:FULC) have lost more than 80% of their value since the IPO was priced at $19 in August 2021. Year to date performance is negative 50% after FTX-6058 for sickle cell disease was placed on full clinical hold by the FDA in…

With Finastra Bacsactive-IP, Priority Software’s UK corporate customers can make payments directly through the company’s ERP software LONDON, May 23, 2023 /PRNewswire/ — Finastra, a global provider of financial software applications and marketplaces and one of the largest suppliers of Bacs and Faster Payments Service (FPS) solutions for the UK, today…

ACCESSWIRE2023-05-22 ChatAible users can immediately leverage Google Cloud’s conversational large language models through Vertex AI for enterprise generative AI and data analytics use cases. SAN FRANCISCO, CA / ACCESSWIRE / May 22, 2023 / Aible, the only enterprise AI solution that guarantees impact in 30 days, today announced the general…

Google has unveiled PaLM2, a new language model designed to improve language translation, “reasoning” and coding capabilities. During the Google I/O 2023 event, the tech giant confirmed that it already uses PaLM2 to power 25 products including its conversational AI assistant, Bard. It also powers Med-PaLM2, a medical competency model…

NEW YORK – Arima Genomics is making a concerted push to expand its business into cancer diagnostics, following the demonstration of its sequencing-based chromosome conformation assay kits to identify cancer driver mutations. To help with the effort, the Carlsbad, California-based firm is creating a clinical advisory board, led by New…

ChatAible users can immediately leverage Google Cloud’s conversational large language models through Vertex AI for enterprise generative AI and data analytics use cases. SAN FRANCISCO, May 22, 2023 (Newswire.com) – Aible, the only enterprise AI solution that guarantees impact in 30 days, today announced the general availability of ChatAible, the first…

ChatAible users can immediately leverage Google Cloud’s conversational large language models through Vertex AI for enterprise generative AI and data analytics use cases. SAN FRANCISCO, CA / ACCESSWIRE / May 22, 2023 / Aible, the only enterprise AI solution that guarantees impact in 30 days, today announced the general availability…

“Google will do with AI what Apple did with the iPhone, which will drive consumer demand for the enterprises.” – Pavel Abdur-Rahman, IBM The Google Cloud Summit was held on 18th May 2023. We joined Google Cloud Startup Summit and heard from top VCs, Google experts, and founders to support…

Ipsen Pharma PARIS, FRANCE, 12 August 2022 – Ipsen (Euronext: IPN; ADR: IPSEY) today announced the closing of the definitive merger agreement under which Ipsen has acquired Epizyme, Inc. (Epizyme). Pursuant to the transaction, Ipsen acquires all outstanding shares of Epizyme for $1.45 per share plus a contingent value right (CVR)…

NEW YORK – Oxford Nanopore Technologies said on Thursday that it is rolling out a new direct RNA sequencing kit that the company promises will “significantly” increase the raw read accuracy as well as data output. While Oxford Nanopore has been known for its relatively rapid product turnover for DNA applications,…

Meta “MTIA” V1 (Meta Training and Inference Accelerator) die shot Meta When most people think about Meta, they think about its apps, including Facebook, Instagram, WhatsApp, or the upcoming metaverse. Many don’t know that the company has designed and built some of the world’s largest and most sophisticated datacenters to…

Join top executives in San Francisco on July 11-12, to hear how leaders are integrating and optimizing AI investments for success. Learn More Meta, the social media giant formerly known as Facebook, has been a pioneer in artificial intelligence (AI) for more than a decade, using it to power its…

//php echo do_shortcode(‘[responsivevoice_button voice=”US English Male” buttontext=”Listen to Post”]’) ?> Nvidia will make Cambridge-1, the supercomputer it launched for the U.K. healthcare and life sciences research sector, accessible through its DGX-Cloud offering. One of the first Nvidia installations to join the DGX-Cloud, Cambridge-1 has been “hugely successful” since it launched…

PARIS, FRANCE, 12 August 2022 – Ipsen (Euronext: IPN; ADR: IPSEY) today announced the closing of the definitive merger agreement under which Ipsen has acquired Epizyme, Inc. (Epizyme). Pursuant to the transaction, Ipsen acquires all outstanding shares of Epizyme for $1.45 per share plus a contingent value right (CVR) of $1.00…

Adhikari HS, Yadav PN (2018) Anticancer activity of chitosan, chitosan derivatives, and their mechanism of action. Int J Biomater 2018:1–29 Google Scholar  Aider M (2010) Chitosan application for active bio-based films production and potential in the food industry. LWT-Food Sci Technol 43:837–842 CAS  Google Scholar  Ash K, Ramteke PW (2018)…

IRVINE, Calif., May 17, 2023 /PRNewswire/ — Zymo Research, a leading provider of microbiology research tools, has officially launched its Full-Length 16S Sequencing Service, offering researchers high-quality, full-length 16S rRNA gene sequencing for microbiome analysis. Zymo Research Corp. Logo The new full-length 16S service provides researchers with greater species resolution and…

BOSTON – Amazon Web Services this week introduced new features for its nascent Amazon Omics service, including a collection of “pre-built” workflows, support for graphical processing units (GPUs), direct data uploads through an application programming interface (API), and streamlined variant querying and analysis. AWS launched Amazon Omics last November. The…

PITTSBURGH, May 16, 2023 (GLOBE NEWSWIRE) — NeuBase Therapeutics, Inc. (Nasdaq: NBSE) (“NeuBase” or the “Company”), a biotechnology company developing Stealth Editors™ to perform in vivo gene editing without triggering the immune system, today announced the formation of a gene editing advisory board comprised of distinguished leaders of the scientific community…

Gene Editing Services Deliver Disease Relevant Cell Models to Improve Preclinical Drug Development SAN DIEGO, May 16, 2023–(BUSINESS WIRE)–iXCells Biotechnologies (“iXCells” or the “Company”), a provider of cell products and drug discovery services to the worldwide academic, biotech and pharmaceutical communities, today announced expansion of its CRISPR-Cas9 product and custom…

Almac Diagnostic Services, a member of the Almac Group, has announced significant updates to claraT, its unique software-driven solution for gene expression data analysis, which gives cancer researchers access to the most comprehensive and robust biomarker discovery support available.  Almac’s claraT, which has supported over 60 oncology studies to date…

Abeona Therapeutics Inc. Animal proof-of-concept for AAV-based gene therapies for Stargardt disease, X-linked retinoschisis and autosomal dominant optic atrophy CLEVELAND, May 16, 2023 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced new data regarding three internally developed preclinical gene therapy product candidates from its adeno-associated virus (AAV) ophthalmology…

Assad Ahmed, Founding Director at Phase 3 Unit4 has announced a strategic partnership with Phase 3, a provider of managed services for HR, Payroll and Finance technologies. In this partnership, Phase 3 aims to implement and integrate Unit4 HCM to optimize employee processes, boost productivity and increase the accuracy of…

This approach is defined as being used to express transcription factor combinations to reprogram human induced pluripotent stem cells (iPSCs). Mekonos, Inc. announced a new research collaboration with bit.bio on May 4, 2023 to test and optimize non-viral delivery of bit.bio’s patented safe harbor gene-targeting approach. This approach is defined…

Noone AM, Howlader N, Krapcho M, Miller D, Brest A, Yu M, et al., editors. SEER Cancer Statistics Review, 1975-2015. 2018;Available from: seer.cancer.gov/csr/1975_2015/. Bonadonna G, Brusamolino E, Valagussa P, Rossi A, Brugnatelli L, Brambilla C, et al. Combination chemotherapy as an adjuvant treatment in operable breast cancer. N Engl J…

As the CEO of ChatGPT developer OpenAI prepares to testify before the U.S. Senate next week about potential regulation surrounding generative AI, Google leaned into the tech at its annual I/O conference for developers, announcing plans to use generative AI to enhance a number of its core experiences, including search….

Google hosted its biggest event of the year. At the annual Google I/O 2023 developer conference, the tech giant gave a glimpse of Android 14 along with expected launches of its first foldable phone – Pixel Fold, Pixel 7a, and Pixel Tablet.  On the sfotware side, the company introduced features…

IBM, the tech giant, has proposed to join the AI rally as it announces ‘Watsonx,’ its new AI platform. The announcement came out at the company’s annual Think conference. This announcement has somehow created a buzz among the back-office managers of the company because they were recently told that the…

Join top executives in San Francisco on July 11-12, to hear how leaders are integrating and optimizing AI investments for success. Learn More Google kicked off its annual I/O conference today with a core focus on what it’s doing to advance artificial intelligence (AI) across its domain. (Spoiler alert: It’s…

Lightning AI is a platform for building machine learning and publishing Lightning Apps that glue together lifecycle tools. To learn more about Lightning AI, Pulse 2.0 interviewed Lightning AI CEO William Falcon. William Falcon’s Background Falcon grew up in Venezuela and came to the United States when he was a…

The partnership further emphasizes Jasper’s mission to provide secured and accessible, on-brand content. AUSTIN, Texas , May 9, 2023 /PRNewswire/ — Jasper, an artificial intelligence (AI) content platform today announced a deepening partnership with Google Cloud. The partnership makes Jasper available to millions within the Google Cloud Marketplace, adds yet…

Company successfully submits GTX-104 Pivotal Phase 3 protocol IND amendment to the FDA with expectation for first patient dosed in calendar Q4 2023 Strategic realignment prioritizes GTX-104 and expects to extend cash runway through a potential New Drug Application (NDA) filing for GTX-104 LAVAL, Québec, May 8, 2023 /PRNewswire/ —…

Company successfully submits GTX-104 Pivotal Phase 3 protocol IND amendment to the FDA with expectation for first patient dosed in calendar Q4 2023 Strategic realignment prioritizes GTX-104 and expects to extend cash runway through a potential New Drug Application (NDA) filing for GTX-104 LAVAL, Québec, May 8, 2023 /PRNewswire/ — Acasti…

Acasti Pharma (NASDAQ:) Inc. (“Acasti” or the “Company”) (Nasdaq: ACST), a late-stage, biopharma company advancing GTX-104, its novel formulation of nimodipine that addresses the high unmet medical needs for a rare disease, aneurysmal subarachnoid hemorrhage (aSAH), today announced the successful submission to the FDA of GTX-104’s full protocol of its…

SNIPR Biome ApS (“SNIPR”), the company pioneering CRISPR-based microbial gene therapy, announces today that Nature Biotechnology has published research findings from its preclinical work on  SNIPR001, the first CRISPR-armed phage therapeutic developed to specifically target and remove E. coli, including antibiotic-resistant strains, in the human gastrointestinal tract. The emergence of…

About Tareef Kawaf is the current president at RStudio. Tareef has over 25 years of experience in the technology industry, and has held various leadership positions at Brightcove, Inc., Ruckus Network, ATG, and Digital Equipment Corporation. Kawaf was responsible for recruiting and mentoring a world-class engineering team at Brightcove, Inc.,…

Introduction Nontuberculous mycobacteria (NTM), a mycobacterium other than the Mycobacterium tuberculosis complex (MTC) and M. leprae, are conditional pathogens widely found in the environment.1 Studies have shown that the probability of NTM transmission is extremely low, and exposure comes primarily from the environment, soil, water, etc.1 In recent years, lung…

Contributed Commentary by Linda De Jesus, VP/GM, Integrated Data Technologies Global Head of Commercial  May 5, 2023 | Next-generation sequencing (NGS) has revolutionized molecular biology and served as a universal tool for many research avenues across the spectrum of biology. NGS has become crucial in various applications. In agriculture, it…

SEATTLE, May 3, 2023 /PRNewswire/ — Sound Pharmaceuticals is pleased to announce that it has completed enrollment in its first Phase 3 clinical trial involving SPI-1005, a novel anti-inflammatory, for the treatment of Meniere’s Disease (STOPMD-3). SPI-1005 is given orally and is the only drug demonstrated to improve both hearing…

Businesses are enthusiastically integrating generative AI tech like ChatGPT into their products and services. And that trend is only set to skyrocket according to the companies we spoke with.Accenture says the industry is at a phase in the adoption cycle when most organisations are starting to experiment by consuming large…

GitLab AI-powered security feature to leverage Google Cloud’s foundation models to empower customers to identify and remediate vulnerabilities more efficiently while maintaining privacy standards SAN FRANCISCO, May 2, 2023 /PRNewswire/ — GitLab Inc., the most comprehensive, scalable enterprise DevSecOps platform for software innovation, and Google Cloud today announced an extension of…

(Phonlamai Photo/Shutterstock) A new integration for machine learning is available from Teradata and Google Cloud. Google Cloud’s Vertex AI platform is now generally available with Teradata VantageCloud and ClearScape analytics. “With Teradata VantageCloud and ClearScape Analytics plus Vertex AI, organizations can move seamlessly from being AI experimenters to AI achievers,”…

3 Google has announced the launching of an AI-powered platform for improved security. Dubbed the “Google Cloud Security AI Workbench,” the tool aims at improving threat detection and management to facilitate the cybersecurity community. Google Cloud Security AI Workbench To Manage Threat Detection According to a recent post from Google…

Fort Myers, Fla., April 27, 2023 – Florida Cancer Specialists & Research Institute, LLC (FCS) today released a case study outlining the evolution of a newly FDA-approved first-line therapy for adult patients with relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL). The treatment regimen combines use of Polatuzumab Vedotin…

The Knott Laboratory at Cedars-Sinai Medical Center is seeking to hire a highly motivated computational scientist to fill the position of Research Bioinformatician II! The Knott laboratory is searching for a computational scientist with strong software engineering skills. We prefer this person have a background in single cell…

• Mavacamten met the primary endpoint for the treatment of Chinese patients with symptomatic obstructive hypertrophic cardiomyopathy • Mavacamten demonstrated a safety profile consistent with previous studies • If approved, mavacamten is expected to be the first cardiac myosin inhibitor approved in China for the treatment of oHCM • LianBio to host a…

• Mavacamten met the primary endpoint for the treatment of Chinese patients with symptomatic obstructive hypertrophic cardiomyopathy • Mavacamten demonstrated a safety profile consistent with previous studies • If approved, mavacamten is expected to be the first cardiac myosin inhibitor approved in China for the treatment of oHCM • LianBio to host a…

Norwegian biotech Targovax recently said it’s planning to rebrand as Circio, marking its shift from clinical stage immuno-oncology company to one focused on circular RNA (circRNA) therapeutics. The name change is subject to approval by Targovax’s shareholders, who are set to vote at the company’s annual general meeting on May…

Researchers from Tel Aviv University in Israel have revealed details of a new approach to the treatment of ovarian cancer using RNA-based nanodrugs – demonstrating an 80% survival rate in lab models.In a study at Tel Aviv University, the protein CKAP5 (cytoskeleton-associated protein) was used for the first time as…

ACMG: Melanie Wells Melanie Wells has been named as the new CEO of the American College of Medical Genetics and Genomics. The first African American and the first woman to lead the organization, Wells will succeed ACMG interim CEO Robert Best. Wells joined the ACMG and the ACMG Foundation in 2016…

Introduction Increasing antibiotic resistance is a worrisome trend being observed worldwide. Methicillin-resistant Staphylococcus aureus (MRSA) was first reported in the United Kingdom (UK) in 1961 and has since been reported throughout the world as a nosocomial pathogen.1 A steady increase in the occurrence of MRSA strains has been reported in…

NEWS RELEASE: Promex Bolsters Leadership Team with David Fromm as Vice President of Engineering Promex Industries, a Silicon Valley-based provider of advanced microelectronic component assembly and design services for the medtech and biotech industries, today announced the recent hire for Vice President of Engineering, David Fromm. With a long and…

· The name Circio encapsulates the strategic shift to focus on the innovative, proprietary circular RNA (circRNA) platform · circRNA has the potential to outperform mRNA, and Circio’s pipeline is initially targeting cancer, with plans to rapidly expand into vaccines and gene therapy · International patent applications covering Circio’s vector…

SAN DIEGO , April 19, 2023 /PRNewswire/ — The ongoing exhibition ‘ Of Genes and Human Beings ‘ at the national German DHMD museum in Dresden, highlights multiple technological advances in the genetic field over the last century and especially the last 20 years. Cardea Bio’s BPU variant, the CRISPR-chip…

U.S. Central Command is hiring an AI advisor from Google to accelerate the adoption of emerging technologies across U.S. military services in the Middle East, Defense One has learned.  Andrew Moore ​​has served as general manager and VP for the AI division of Google Cloud, where he was responsible for…

About Steve Nolen is currently a Site Reliability Engineer at RStudio. Prior to that, they were a Systems Administrator/Engineer at UCLA from January 2012 to October 2016. Steve has also worked as a Help Desk Consultant at Penn State University from August 2010 to December 2011 and as a Technician/Assistant…

In the last article in this series on AI and machine learning, we developed further insights on the workings of neural networks. Subsequently, we enhanced our understanding of unsupervised learning through the use of scikit-learn. Finally, we embarked on learning PyTorch, a machine learning framework built on the Torch library….

Hi, The problem that you got is related with the fact that you need to provide a list of comparisons to be made to the function stat_compare_means(), and you are providing a character/factor variable. So, if you adjust your code to: vp_case1 <- function(gene_signature, file_name, test_sign, y_max){ plot_case1 <- function(signature){…

Chemically defined media optimized for growth and productivity of CHO cells in perfusion and batch and fed-batch bioprocesses. Manufactured to cGMP-compliant standards to support production of recombinant proteins, monoclonal antibodies, and biosimilars FUJIFILM Irvine Scientific, Inc., a global leader in the innovation and manufacture of cell culture solutions for Life…

Lives are saved when time from vein to vein decreases. Therapeutic biologics are thriving, according to Zhou Jiang, director Cell Culture Services at Cytiva. “As we work to advance the next generation of therapeutics, we must address these challenges to deliver the medicines patients need. The increasing diversity introduces new…

The BalanCD CHO media portfolio is designed to ensure maximized growth, viability, and productivity of CHO cell lines. FUJIFILM Irvine Scientific, Inc. announced its growth of the BalanCD Chinese Hamster Ovary (CHO) Media Platform portfolio with the addition of two new, chemically defined growth media- BalanCD CHO Perfusion and BalanCD…

NEW YORK – Foundation Medicine said Tuesday that it has expanded an ongoing collaboration with Bristol Myers Squibb to include companion diagnostic development for the pharma firm’s investigational tyrosine kinase inhibitor repotrectinib. Repotrectinib is an orally administered tyrosine kinase inhibitor that is being evaluated in an ongoing registrational Phase I/II…

BalanCD CHO Perfusion is a chemically defined medium that is optimized for the growth and production of suspension CHO cell cultures in continuous, steady-state, and N-1 perfusion cultures. As a high performing medium, it can achieve key perfusion metrics including cell-specific productivity, volumetric productivity, and cell-specific perfusion rate (CSPR). BalanCD…

ICTV. Virus Taxonomy: 2021 Release—Order Herpesvirales (International Committee on Taxonomy of Viruses, ICTV, 2021). Google Scholar  Headley, S. A., Oliveira, T. E. S. & Cunha, C. W. A review of the epidemiological, clinical, and pathological aspects of malignant catarrhal fever in Brazil. Braz. J. Microbiol. 51, 1405–1432. doi.org/10.1007/s42770-020-00273-6 (2020). Article …

Details Open Date 04/05/2023 Requisition Number PRN34456B Job Title Bioinformatics Data Analyst I Working Title Bioinformatics Data Analyst I Job Grade F FLSA Code Administrative Patient Sensitive Job Code? No Standard Hours per Week 40 Full Time or Part Time? Full Time Shift Day Work Schedule Summary VP Area President…

NEW YORK – Elegen, a Bay Area startup founded by Natera’s former head of R&D, is making a splash in the synthetic DNA market by promising longer DNA than can currently be made by the highest-throughput manufacturers. Offering synthetic DNA of 1 Kb to 7 Kb with high accuracy and…

The biotechnology industry is largely an enterprise based on a small sampling of life. Biotechnologies and biomanufacturing are dominated by a few bacterial, fungal and animal cell systems. Taking away Escherichia coli, Bacillus subtilis, Saccharomyces cerevisiae, Aspergillus niger, Trichoderma, HEK293 and CHO cells, what remains of the industry? While these…

This comparative study of lichen-associated bacteria found that lichen samples VP-CM-021 and VP-CM-023 had the greatest species richness and phylogenetic diversity. Both belonged to the genus Heterodermia, a lichen genus typically found in tropical and subtropical regions22. Previous research showed that the most abundant bacteria in the lichen Heterodermia obscurata…